Search results
Results from the WOW.Com Content Network
Common adverse drug reactions (≥1% of those treated with the drug) associated with systemic metronidazole therapy include: nausea, diarrhea, weight loss, abdominal pain, vomiting, headache, dizziness, and metallic taste in the mouth. Intravenous administration is commonly associated with thrombophlebitis.
In the United States, the Food and Drug Administration (FDA) determines the requirements for patient package inserts. In the United States, the FDA will occasionally issue revisions to previously approved package inserts, in much the same way as an auto manufacturer will issue recalls upon discovering a problem with a certain car.
The primary role of this section of labeling is to enable health care practitioners to readily identify appropriate therapies for patients by clearly communicating the drug's approved indication(s). The Indications and Usage section states the disease or condition, or manifestation or symptoms thereof, for which the drug is approved, as well as ...
The approval of Appili's drug could help ease the metronidazole shortage in the U.S., especially for patients in hospitalized settings and those with severe infections, who are affected most by ...
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
According to the New York Times, here's exactly how to play Strands: Find theme words to fill the board. Theme words stay highlighted in blue when found.
granted for two indications: mast cell leukemia and advanced systemic mastocytosis: Belumosudil: Kadmon Pharmaceuticals: chronic graft-versus-host disease: Pembrolizumab: Merck: high risk, early-stage triple-negative breast cancer: Avalglucosidase alfa: Genzyme: late-onset Pompe disease: Lenvatinib: Eisai Inc
Giardiasis with a high level of drug resistance may even require a combination of mepacrine and metronidazole to cure. [ 2 ] Mepacrine is also used off-label for the treatment of systemic lupus erythematosus , [ 3 ] indicated in the treatment of discoid and subcutaneous lupus manifestations, particularly in patients who are unable to take ...